Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
hypoxia-inducible factor 1 alpha subunit | 6 | 0 | 0 | 6 |
RAR-related orphan receptor gamma | 19 | 0 | 0 | 19 |
GLI family zinc finger 3 | 19 | 0 | 0 | 19 |
AR protein | 23 | 0 | 0 | 23 |
aldehyde dehydrogenase 1 family, member A1 | 13 | 0 | 0 | 13 |
retinoic acid nuclear receptor alpha variant 1 | 22 | 0 | 0 | 22 |
retinoid X nuclear receptor alpha | 17 | 0 | 0 | 17 |
estrogen nuclear receptor alpha | 29 | 0 | 0 | 29 |
peroxisome proliferator-activated receptor delta | 10 | 0 | 0 | 10 |
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 12 | 0 | 0 | 12 |
activating transcription factor 6 | 9 | 0 | 0 | 9 |
v-jun sarcoma virus 17 oncogene homolog (avian) | 7 | 0 | 0 | 7 |
Histone H2A.x | 9 | 0 | 0 | 9 |
thyroid hormone receptor beta isoform a | 11 | 0 | 0 | 11 |
heat shock protein beta-1 | 7 | 0 | 0 | 7 |
nuclear factor erythroid 2-related factor 2 isoform 1 | 22 | 0 | 0 | 22 |
lamin isoform A-delta10 | 12 | 0 | 0 | 12 |
Voltage-dependent calcium channel gamma-2 subunit | 9 | 0 | 0 | 9 |
Glutamate receptor 2 | 9 | 3 | 1 | 13 |
Solute carrier family 22 member 3 | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 2C | 0 | 3 | 1 | 4 |
Phenylethanolamine N-methyltransferase | 0 | 2 | 0 | 2 |
Cytochrome P450 2A6 | 0 | 2 | 0 | 2 |
Substance-P receptor | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 2A | 0 | 3 | 3 | 6 |
5-hydroxytryptamine receptor 1A | 0 | 7 | 2 | 9 |
Cytochrome P450 2A5 | 0 | 1 | 0 | 1 |
Sodium-dependent dopamine transporter | 0 | 3 | 0 | 3 |
5-hydroxytryptamine receptor 1B | 0 | 4 | 1 | 5 |
5-hydroxytryptamine receptor 1D | 0 | 2 | 1 | 3 |
5-hydroxytryptamine receptor 1F | 0 | 2 | 1 | 3 |
5-hydroxytryptamine receptor 2B | 0 | 3 | 1 | 4 |
5-hydroxytryptamine receptor 6 | 0 | 0 | 1 | 1 |
5-hydroxytryptamine receptor 7 | 0 | 2 | 2 | 4 |
5-hydroxytryptamine receptor 5A | 0 | 0 | 1 | 1 |
5-hydroxytryptamine receptor 5B | 0 | 0 | 1 | 1 |
5-hydroxytryptamine receptor 3A | 0 | 0 | 1 | 1 |
Sigma non-opioid intracellular receptor 1 | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 4 | 0 | 1 | 1 | 2 |
Beta-2 adrenergic receptor | 0 | 1 | 1 | 2 |
5-hydroxytryptamine receptor 3B | 0 | 0 | 1 | 1 |
Sigma non-opioid intracellular receptor 1 | 0 | 1 | 0 | 1 |
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 8 | 0 | 0 | 8 |
Chain A, Mutant Al2 6e7p9g | 0 | 0 | 1 | 1 |
Chain A, Beta-lactamase | 8 | 0 | 0 | 8 |
Chain A, 2-oxoglutarate Oxygenase | 9 | 0 | 0 | 9 |
Chain A, ATP-DEPENDENT DNA HELICASE Q1 | 5 | 0 | 0 | 5 |
Chain A, Cruzipain | 4 | 0 | 0 | 4 |
Beta-lactamase | 0 | 0 | 0 | 1 |
acid sphingomyelinase | 1 | 0 | 0 | 1 |
GLS protein | 7 | 0 | 0 | 7 |
apical membrane antigen 1, AMA1 | 2 | 0 | 0 | 2 |
farnesoid X nuclear receptor | 13 | 0 | 0 | 13 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Metallo-beta-lactamase type 2 | 0 | 0 | 0 | 1 |
Metallo-beta-lactamase VIM-11 | 0 | 0 | 0 | 1 |
euchromatic histone-lysine N-methyltransferase 2 | 20 | 0 | 0 | 20 |
Metallo-beta-lactamase VIM-2 | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Metallo-beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 5 | 0 | 0 | 5 |
chromobox protein homolog 1 | 13 | 0 | 0 | 13 |
thyroid hormone receptor beta isoform 2 | 16 | 0 | 0 | 16 |
DNA polymerase beta | 3 | 0 | 0 | 3 |
DNA polymerase eta isoform 1 | 1 | 0 | 0 | 1 |
DNA polymerase iota isoform a (long) | 7 | 0 | 0 | 7 |
geminin | 16 | 0 | 0 | 16 |
DNA polymerase kappa isoform 1 | 7 | 0 | 0 | 7 |
Carbonic anhydrase 1 | 0 | 5 | 0 | 6 |
Carbonic anhydrase 2 | 0 | 5 | 0 | 6 |
60 kDa heat shock protein, mitochondrial | 0 | 3 | 0 | 3 |
Beta-lactamase OXA-7 | 0 | 0 | 0 | 1 |
Solute carrier family 15 member 1 | 0 | 2 | 0 | 2 |
Solute carrier family 15 member 1 | 0 | 1 | 0 | 1 |
Spike glycoprotein | 4 | 0 | 0 | 4 |
10 kDa heat shock protein, mitochondrial | 0 | 3 | 0 | 3 |
Angiopoietin-1 receptor | 0 | 0 | 1 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Solute carrier family 15 member 2 | 0 | 1 | 0 | 1 |
Thiosulfate sulfurtransferase | 0 | 3 | 0 | 3 |
Metallo-beta-lactamase VIM-13 | 0 | 0 | 0 | 1 |
Efflux transporter | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase Toho-1 | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Class D beta-lactamase | 0 | 0 | 0 | 1 |
60 kDa chaperonin | 0 | 3 | 0 | 3 |
Metallo-beta-lactamase | 0 | 0 | 0 | 1 |
Solute carrier family 15 member 2 | 0 | 1 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
10 kDa chaperonin | 0 | 3 | 0 | 3 |
Metallo-b-lactamase | 0 | 0 | 0 | 1 |
Carbapenem-hydrolyzing beta-lactamase KPC | 0 | 0 | 0 | 1 |
Histamine H3 receptor | 0 | 0 | 0 | 1 |
Beta-lactamase class B VIM-2 | 0 | 0 | 0 | 1 |
Beta-lactamase VIM-1 | 0 | 0 | 0 | 1 |
ATP-dependent phosphofructokinase | 7 | 0 | 0 | 7 |
thyroid stimulating hormone receptor | 6 | 0 | 0 | 6 |
vitamin D (1,25- dihydroxyvitamin D3) receptor | 13 | 0 | 0 | 13 |
Steroid C26-monooxygenase | 0 | 0 | 1 | 1 |
Cytochrome P450 130 | 0 | 0 | 1 | 1 |
Cytochrome P450 130 | 0 | 0 | 1 | 1 |
thioredoxin reductase | 14 | 0 | 0 | 14 |
ATAD5 protein, partial | 8 | 0 | 0 | 8 |
TDP1 protein | 25 | 0 | 0 | 25 |
Microtubule-associated protein tau | 10 | 0 | 0 | 10 |
estrogen-related nuclear receptor alpha | 24 | 0 | 0 | 24 |
arylsulfatase A | 8 | 0 | 0 | 8 |
Bloom syndrome protein isoform 1 | 7 | 0 | 0 | 7 |
D(1A) dopamine receptor | 4 | 0 | 0 | 4 |
neuropeptide S receptor isoform A | 2 | 0 | 0 | 2 |
vitamin D3 receptor isoform VDRA | 7 | 0 | 0 | 7 |
peripheral myelin protein 22 | 9 | 0 | 0 | 9 |
ATP-binding cassette sub-family C member 3 | 0 | 9 | 0 | 9 |
Multidrug resistance-associated protein 4 | 0 | 9 | 0 | 9 |
Bile salt export pump | 0 | 14 | 0 | 14 |
Translocator protein | 0 | 0 | 1 | 1 |
Vasopressin V2 receptor | 0 | 2 | 1 | 4 |
Oxytocin receptor | 0 | 1 | 1 | 2 |
Vasopressin V1a receptor | 0 | 0 | 2 | 2 |
Vasopressin V1a receptor | 0 | 1 | 1 | 2 |
Vasopressin V1b receptor | 0 | 1 | 1 | 2 |
Vasopressin V2 receptor | 0 | 0 | 1 | 1 |
Vasopressin V1b receptor | 0 | 1 | 1 | 3 |
Translocator protein | 0 | 1 | 0 | 2 |
Oxytocin receptor | 0 | 1 | 0 | 1 |
Vasopressin V2 receptor | 0 | 1 | 1 | 2 |
Canalicular multispecific organic anion transporter 1 | 0 | 9 | 0 | 9 |
nuclear receptor subfamily 1, group I, member 3 | 18 | 0 | 0 | 18 |
thyroid stimulating hormone receptor | 10 | 0 | 0 | 10 |
Cellular tumor antigen p53 | 16 | 0 | 0 | 16 |
Nuclear receptor ROR-gamma | 6 | 1 | 1 | 8 |
interleukin 8 | 4 | 0 | 0 | 4 |
pregnane X receptor | 7 | 0 | 0 | 7 |
progesterone receptor | 10 | 0 | 0 | 10 |
glucocorticoid receptor [Homo sapiens] | 15 | 0 | 0 | 15 |
pregnane X nuclear receptor | 14 | 0 | 0 | 14 |
bromodomain adjacent to zinc finger domain 2B | 4 | 0 | 0 | 4 |
IDH1 | 6 | 0 | 0 | 6 |
nuclear receptor subfamily 1, group I, member 2 | 2 | 0 | 0 | 2 |
cellular tumor antigen p53 isoform a | 4 | 0 | 0 | 4 |
Nuclear hormone receptor family member daf-12 | 0 | 0 | 1 | 1 |
nuclear factor erythroid 2-related factor 2 isoform 2 | 6 | 0 | 0 | 6 |
serine/threonine-protein kinase mTOR isoform 1 | 3 | 0 | 0 | 3 |
oxysterols receptor LXR-beta isoform 1 | 0 | 0 | 1 | 1 |
urokinase-type plasminogen activator precursor | 4 | 0 | 0 | 4 |
plasminogen precursor | 4 | 0 | 0 | 4 |
urokinase plasminogen activator surface receptor precursor | 4 | 0 | 0 | 4 |
survival motor neuron protein isoform d | 5 | 0 | 0 | 5 |
muscarinic acetylcholine receptor M1 | 5 | 0 | 0 | 5 |
Thymidine kinase, cytosolic | 0 | 4 | 0 | 6 |
Thymidine phosphorylase | 0 | 0 | 0 | 2 |
Thymidylate kinase | 0 | 2 | 0 | 2 |
Thymidine kinase | 0 | 0 | 0 | 2 |
Thymidylate kinase | 0 | 2 | 0 | 2 |
ATPase family AAA domain-containing protein 5 | 8 | 0 | 0 | 8 |
Ataxin-2 | 10 | 0 | 0 | 10 |
acetylcholinesterase | 9 | 0 | 0 | 9 |
USP1 protein, partial | 9 | 0 | 0 | 9 |
mitogen-activated protein kinase 1 | 7 | 0 | 0 | 7 |
Vpr | 2 | 0 | 0 | 2 |
Bile salt export pump | 0 | 4 | 0 | 4 |
Albumin | 0 | 0 | 1 | 1 |
Major prion protein | 0 | 0 | 2 | 2 |
Sodium channel protein type 1 subunit alpha | 0 | 1 | 0 | 1 |
Sodium channel protein type 2 subunit alpha | 0 | 2 | 0 | 2 |
Sodium channel protein type 3 subunit alpha | 0 | 1 | 0 | 1 |
Cytochrome P450 2C9 | 0 | 2 | 1 | 3 |
UDP-glucuronosyltransferase 2B7 | 0 | 1 | 0 | 3 |
Cytochrome P450 2B6 | 0 | 0 | 1 | 1 |
Sodium channel protein type 4 subunit alpha | 0 | 2 | 0 | 4 |
Cytochrome P450 2J2 | 0 | 1 | 0 | 1 |
Potassium voltage-gated channel subfamily H member 2 | 0 | 2 | 0 | 2 |
Sodium channel protein type 9 subunit alpha | 0 | 3 | 0 | 3 |
Frizzled-8 | 0 | 0 | 1 | 1 |
P2X purinoceptor 4 | 0 | 1 | 0 | 1 |
Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 6 | 0 | 0 | 6 |
Chain A, Breast cancer type 1 susceptibility protein | 1 | 0 | 0 | 1 |
Chain A, Putative fructose-1,6-bisphosphate aldolase | 4 | 0 | 0 | 4 |
Chain A, HADH2 protein | 3 | 0 | 0 | 3 |
Chain B, HADH2 protein | 3 | 0 | 0 | 3 |
Chain A, JmjC domain-containing histone demethylation protein 3A | 4 | 0 | 0 | 4 |
Chain A, Ferritin light chain | 4 | 0 | 0 | 4 |
Luciferase | 7 | 0 | 0 | 7 |
Nrf2 | 2 | 0 | 0 | 2 |
15-lipoxygenase, partial | 2 | 0 | 0 | 2 |
phosphopantetheinyl transferase | 9 | 0 | 0 | 9 |
SMAD family member 2 | 8 | 0 | 0 | 8 |
SMAD family member 3 | 8 | 0 | 0 | 8 |
alkaline phosphatase, intestinal | 0 | 1 | 0 | 1 |
thioredoxin glutathione reductase | 5 | 0 | 0 | 5 |
Smad3 | 3 | 0 | 0 | 3 |
caspase 7, apoptosis-related cysteine protease | 1 | 0 | 0 | 1 |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 4 | 0 | 0 | 4 |
PINK1 | 1 | 0 | 0 | 1 |
estrogen receptor 2 (ER beta) | 9 | 0 | 0 | 9 |
EWS/FLI fusion protein | 2 | 0 | 0 | 3 |
glucocerebrosidase | 1 | 0 | 0 | 1 |
Parkin | 2 | 0 | 0 | 2 |
toll-like receptor 9 | 0 | 1 | 0 | 1 |
peroxisome proliferator activated receptor gamma | 11 | 0 | 0 | 11 |
caspase-3 | 1 | 0 | 0 | 1 |
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) | 4 | 0 | 0 | 4 |
TPA: protein transporter TIM10 | 0 | 1 | 0 | 1 |
aryl hydrocarbon receptor | 9 | 0 | 0 | 9 |
thyrotropin-releasing hormone receptor | 5 | 0 | 0 | 5 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 5 | 0 | 0 | 5 |
lysosomal alpha-glucosidase preproprotein | 3 | 0 | 0 | 3 |
alkaline phosphatase, tissue-nonspecific isozyme isoform 1 preproprotein | 0 | 1 | 0 | 1 |
hemoglobin subunit beta | 1 | 0 | 0 | 1 |
polyunsaturated fatty acid lipoxygenase ALOX12 | 1 | 0 | 0 | 1 |
perilipin-5 | 0 | 1 | 0 | 1 |
intestinal alkaline phosphatase precursor | 0 | 1 | 0 | 1 |
perilipin-1 | 0 | 1 | 0 | 1 |
potassium voltage-gated channel subfamily H member 2 isoform d | 4 | 0 | 0 | 4 |
transcriptional regulator ERG isoform 3 | 3 | 0 | 0 | 3 |
huntingtin isoform 2 | 1 | 0 | 0 | 1 |
importin subunit beta-1 isoform 1 | 1 | 0 | 0 | 1 |
pyruvate kinase PKM isoform a | 1 | 0 | 0 | 1 |
nuclear factor NF-kappa-B p105 subunit isoform 1 | 1 | 0 | 0 | 1 |
flap endonuclease 1 | 3 | 0 | 0 | 3 |
snurportin-1 | 1 | 0 | 0 | 1 |
histone-lysine N-methyltransferase 2A isoform 2 precursor | 3 | 0 | 0 | 3 |
peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 4 | 0 | 0 | 4 |
tumor susceptibility gene 101 protein | 2 | 0 | 0 | 2 |
GTP-binding nuclear protein Ran isoform 1 | 1 | 0 | 0 | 1 |
nuclear receptor ROR-gamma isoform 1 | 7 | 0 | 0 | 7 |
1-acylglycerol-3-phosphate O-acyltransferase ABHD5 isoform a | 0 | 1 | 0 | 1 |
cytochrome P450 3A4 isoform 1 | 7 | 0 | 0 | 7 |
muscleblind-like protein 1 isoform 1 | 2 | 0 | 0 | 2 |
DNA dC->dU-editing enzyme APOBEC-3G isoform 1 | 2 | 0 | 0 | 2 |
alkaline phosphatase, germ cell type preproprotein | 0 | 1 | 0 | 1 |
caspase-1 isoform alpha precursor | 1 | 0 | 0 | 1 |
hypothetical protein SA1422 | 0 | 1 | 0 | 1 |
lethal factor (plasmid) | 5 | 0 | 0 | 5 |
DNA dC->dU-editing enzyme APOBEC-3F isoform a | 1 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit pi | 7 | 1 | 1 | 9 |
Prostaglandin E synthase | 0 | 1 | 0 | 1 |
Polyunsaturated fatty acid lipoxygenase ALOX15B | 3 | 0 | 0 | 3 |
Histone deacetylase 3 | 0 | 3 | 0 | 3 |
Acetylcholinesterase | 0 | 1 | 0 | 1 |
Lysine-specific histone demethylase 1A | 0 | 2 | 0 | 2 |
D-amino-acid oxidase | 0 | 1 | 0 | 1 |
Phospholipase A2 | 0 | 1 | 0 | 1 |
Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | 0 | 2 | 0 | 2 |
Amyloid-beta precursor protein | 0 | 3 | 0 | 4 |
Integrin beta-3 | 2 | 0 | 1 | 3 |
Neuronal proto-oncogene tyrosine-protein kinase Src | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 1 | 0 | 2 | 0 | 2 |
Cholinesterase | 0 | 2 | 0 | 2 |
Heme oxygenase 1 | 0 | 1 | 0 | 1 |
Integrin alpha-IIb | 2 | 0 | 1 | 3 |
Glutathione S-transferase P | 0 | 1 | 0 | 1 |
Polyunsaturated fatty acid 5-lipoxygenase | 0 | 2 | 0 | 2 |
60 kDa chaperonin | 0 | 2 | 0 | 2 |
Replicase polyprotein 1ab | 0 | 1 | 1 | 2 |
Replicase polyprotein 1ab | 0 | 3 | 1 | 4 |
Microtubule-associated protein tau | 0 | 1 | 0 | 2 |
Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 | 0 | 1 | 0 | 1 |
Tissue factor | 0 | 2 | 0 | 2 |
Tyrosinase | 0 | 1 | 0 | 1 |
Aminopeptidase N | 0 | 1 | 0 | 1 |
Aminopeptidase N | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit beta-1 | 7 | 1 | 1 | 9 |
Alpha-1B adrenergic receptor | 0 | 5 | 0 | 5 |
Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 | 0 | 2 | 0 | 2 |
Glycogen synthase kinase-3 beta | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit delta | 7 | 1 | 1 | 9 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 7 | 1 | 1 | 9 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 7 | 1 | 1 | 9 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 7 | 1 | 1 | 9 |
Amine oxidase [flavin-containing] A | 0 | 2 | 0 | 2 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 1 | 0 | 1 |
Acetylcholinesterase | 0 | 4 | 0 | 4 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 7 | 1 | 1 | 9 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 7 | 1 | 1 | 9 |
Heme oxygenase 2 | 0 | 1 | 0 | 1 |
Alpha-1D adrenergic receptor | 0 | 5 | 0 | 5 |
Amine oxidase [flavin-containing] B | 0 | 2 | 0 | 2 |
Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 1 | 0 | 1 |
Proteasome subunit beta type-5 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 7 | 1 | 1 | 9 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 7 | 1 | 1 | 9 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 7 | 1 | 1 | 9 |
Prostaglandin G/H synthase 2 | 0 | 2 | 0 | 2 |
17-beta-hydroxysteroid dehydrogenase type 2 | 0 | 1 | 0 | 1 |
Alpha-synuclein | 2 | 3 | 1 | 6 |
Alpha-1A adrenergic receptor | 0 | 6 | 0 | 6 |
Histamine H2 receptor | 4 | 0 | 0 | 5 |
Glycogen synthase kinase-3 beta | 0 | 1 | 0 | 1 |
Caspase-7 | 1 | 0 | 0 | 1 |
Histone deacetylase 4 | 0 | 3 | 0 | 3 |
Beta-secretase 1 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 7 | 1 | 1 | 9 |
Gamma-aminobutyric acid receptor subunit beta-3 | 7 | 1 | 1 | 9 |
Guanine nucleotide-binding protein G | 3 | 0 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit beta-2 | 7 | 1 | 1 | 9 |
Cholinesterase | 0 | 2 | 0 | 2 |
Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 1 | 0 | 1 |
Lactoylglutathione lyase | 0 | 1 | 0 | 1 |
Histone acetyltransferase p300 | 0 | 1 | 0 | 1 |
TAR DNA-binding protein 43 | 4 | 0 | 0 | 4 |
Serine/threonine-protein kinase PAK 1 | 0 | 1 | 0 | 1 |
Histone deacetylase 1 | 0 | 4 | 0 | 4 |
5-hydroxytryptamine receptor 4 | 0 | 0 | 1 | 1 |
Sodium/bile acid cotransporter | 0 | 0 | 1 | 1 |
Nuclear factor erythroid 2-related factor 2 | 0 | 0 | 1 | 1 |
Thioredoxin reductase 1, cytoplasmic | 0 | 1 | 0 | 1 |
Thioredoxin reductase 3 | 0 | 1 | 0 | 1 |
Sortase A | 0 | 1 | 0 | 1 |
Histone deacetylase 7 | 0 | 3 | 0 | 3 |
GABA theta subunit | 7 | 1 | 1 | 9 |
Histone deacetylase 2 | 0 | 4 | 0 | 4 |
CREB-binding protein | 0 | 1 | 0 | 1 |
Sarcoplasmic/endoplasmic reticulum calcium ATPase 3 | 0 | 2 | 0 | 2 |
Cysteine protease | 0 | 1 | 0 | 1 |
Polyamine deacetylase HDAC10 | 0 | 3 | 0 | 3 |
Histone deacetylase 11 | 0 | 3 | 0 | 3 |
NACHT, LRR and PYD domains-containing protein 3 | 0 | 1 | 0 | 1 |
Histone deacetylase 8 | 0 | 4 | 0 | 4 |
Gamma-aminobutyric acid receptor subunit epsilon | 7 | 1 | 1 | 9 |
Thioredoxin reductase 2, mitochondrial | 0 | 1 | 0 | 1 |
CDGSH iron-sulfur domain-containing protein 1 | 0 | 2 | 0 | 2 |
Histone deacetylase 6 | 0 | 3 | 0 | 3 |
Histone deacetylase 9 | 0 | 3 | 0 | 3 |
Broad substrate specificity ATP-binding cassette transporter ABCG2 | 0 | 1 | 0 | 1 |
Histone deacetylase 5 | 0 | 3 | 0 | 3 |
Lymphocyte antigen 96 | 0 | 0 | 1 | 1 |
Beta lactamase (plasmid) | 0 | 2 | 0 | 2 |
Integrin beta-1 | 0 | 1 | 0 | 1 |
Integrin alpha-4 | 0 | 1 | 0 | 1 |
Smoothened homolog | 0 | 1 | 0 | 1 |
Sonic hedgehog protein | 0 | 1 | 0 | 1 |
Sonic hedgehog protein | 0 | 1 | 1 | 2 |
Smoothened homolog | 0 | 2 | 1 | 3 |
endonuclease IV | 2 | 0 | 0 | 2 |
glp-1 receptor, partial | 7 | 0 | 0 | 7 |
cytochrome P450 family 3 subfamily A polypeptide 4 | 9 | 0 | 0 | 9 |
G | 6 | 0 | 0 | 6 |
67.9K protein | 4 | 0 | 0 | 4 |
LMP1 [Human herpesvirus 4] | 0 | 0 | 0 | 2 |
nuclear receptor coactivator 1 isoform 1 [Homo sapiens] | 0 | 1 | 0 | 1 |
transactivating tegument protein VP16 [Human herpesvirus 1] | 0 | 1 | 0 | 1 |
nuclear receptor coactivator 3 isoform a | 0 | 1 | 0 | 1 |
Thymidine kinase 2, mitochondrial | 0 | 1 | 0 | 1 |
Interferon beta | 6 | 0 | 0 | 6 |
HLA class I histocompatibility antigen, B alpha chain | 6 | 0 | 0 | 6 |
Thymidine kinase | 0 | 2 | 0 | 3 |
Thymidylate synthase | 0 | 0 | 0 | 2 |
Cytochrome P450 3A4 | 0 | 3 | 1 | 4 |
Thymidine kinase | 0 | 1 | 0 | 1 |
Deoxycytidine kinase | 0 | 0 | 0 | 1 |
Probable deoxycytidylate deaminase | 0 | 0 | 0 | 1 |
Cytidine deaminase | 0 | 1 | 0 | 2 |
D(1A) dopamine receptor | 2 | 0 | 0 | 2 |
E3 ubiquitin-protein ligase Mdm2 | 0 | 1 | 0 | 1 |
Enoyl-[acyl-carrier-protein] reductase [NADH] | 0 | 1 | 0 | 1 |
Inositol hexakisphosphate kinase 1 | 6 | 0 | 0 | 6 |
Thymidine kinase | 0 | 1 | 0 | 2 |
Deoxynucleoside kinase | 0 | 1 | 0 | 1 |
cytochrome P450 2C9, partial | 6 | 0 | 0 | 6 |
NFKB1 protein, partial | 2 | 0 | 0 | 2 |
cytochrome P450 2D6 isoform 1 | 3 | 0 | 0 | 3 |
cytochrome P450 2C19 precursor | 2 | 0 | 0 | 2 |
Genome polyprotein | 0 | 2 | 1 | 3 |
chaperonin-containing TCP-1 beta subunit homolog | 2 | 0 | 0 | 2 |
Fumarate hydratase | 5 | 0 | 0 | 5 |
hypothetical protein, conserved | 2 | 0 | 0 | 2 |
cytochrome P450 2D6 | 7 | 0 | 0 | 7 |
polyprotein | 5 | 0 | 0 | 5 |
ubiquitin carboxyl-terminal hydrolase 2 isoform a | 5 | 0 | 0 | 5 |
eyes absent homolog 2 isoform a | 1 | 0 | 0 | 1 |
lethal(3)malignant brain tumor-like protein 1 isoform I | 1 | 0 | 0 | 1 |
histone acetyltransferase KAT2A isoform 1 | 5 | 0 | 0 | 5 |
relaxin receptor 1 isoform 1 | 1 | 0 | 0 | 1 |
Flavin reductase (NADPH) | 0 | 0 | 1 | 1 |
large T antigen | 0 | 1 | 0 | 1 |
Hsf1 protein | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 38 | 0 | 0 | 0 | 1 |
Chain A, GLUTAMATE RECEPTOR SUBUNIT 2 | 0 | 1 | 0 | 1 |
Chain A, Glutamate Receptor Subunit 2 | 0 | 1 | 0 | 1 |
Chain B, Glutamate Receptor Subunit 2 | 0 | 1 | 0 | 1 |
Chain A, Slr1257 protein | 0 | 0 | 1 | 1 |
Chain A, Glucosamine--fructose-6-phosphate aminotransferase [isomerizing] | 0 | 1 | 0 | 1 |
regulator of G-protein signaling 4 | 5 | 0 | 0 | 5 |
beta-2 adrenergic receptor | 3 | 0 | 0 | 3 |
Metabotropic glutamate receptor 8 | 0 | 2 | 0 | 2 |
Metabotropic glutamate receptor 6 | 0 | 1 | 1 | 3 |
Glutamate receptor ionotropic, NMDA 2D | 0 | 1 | 0 | 1 |
Excitatory amino acid transporter 4 | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 3B | 0 | 1 | 0 | 1 |
Glutathione reductase, mitochondrial | 0 | 3 | 0 | 3 |
Bifunctional aspartokinase/homoserine dehydrogenase 1 | 0 | 1 | 0 | 1 |
Prothrombin | 0 | 0 | 1 | 1 |
ATP-citrate synthase | 0 | 1 | 0 | 1 |
Glutamate receptor 1 | 0 | 3 | 1 | 4 |
Glutamate receptor 3 | 0 | 3 | 1 | 4 |
Glutamate receptor 4 | 0 | 3 | 1 | 4 |
Glutamate receptor ionotropic, kainate 1 | 0 | 2 | 1 | 3 |
Metabotropic glutamate receptor 1 | 0 | 1 | 1 | 2 |
Metabotropic glutamate receptor 2 | 0 | 0 | 1 | 1 |
Metabotropic glutamate receptor 3 | 0 | 0 | 1 | 1 |
Metabotropic glutamate receptor 4 | 0 | 1 | 1 | 2 |
Metabotropic glutamate receptor 5 | 0 | 0 | 1 | 1 |
Metabotropic glutamate receptor 6 | 0 | 0 | 1 | 1 |
Metabotropic glutamate receptor 7 | 0 | 0 | 1 | 1 |
Glutamate receptor ionotropic, NMDA 1 | 0 | 2 | 1 | 3 |
Glutamate receptor ionotropic, kainate 1 | 0 | 1 | 1 | 2 |
Metabotropic glutamate receptor 5 | 0 | 1 | 1 | 3 |
Glutamate receptor ionotropic, kainate 2 | 0 | 2 | 1 | 3 |
Glutamate receptor 1 | 0 | 2 | 1 | 3 |
Glutamate receptor 2 | 0 | 2 | 1 | 3 |
Glutamate receptor 3 | 0 | 1 | 1 | 2 |
Glutamate receptor ionotropic, kainate 3 | 0 | 2 | 0 | 2 |
Excitatory amino acid transporter 1 | 0 | 2 | 0 | 3 |
Excitatory amino acid transporter 2 | 0 | 2 | 0 | 3 |
Excitatory amino acid transporter 3 | 0 | 2 | 0 | 3 |
Metabotropic glutamate receptor 8 | 0 | 0 | 1 | 1 |
Glutamate receptor 4 | 0 | 2 | 1 | 3 |
Excitatory amino acid transporter 3 | 0 | 0 | 0 | 1 |
Glutamate racemase | 0 | 0 | 0 | 1 |
Metabotropic glutamate receptor 8 | 0 | 1 | 1 | 2 |
Fatty-acid amide hydrolase 1 | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2A | 0 | 2 | 1 | 3 |
Glutamate receptor ionotropic, NMDA 2B | 0 | 2 | 1 | 3 |
Glutamate receptor ionotropic, NMDA 2C | 0 | 2 | 1 | 3 |
Glutamate receptor ionotropic, kainate 4 | 0 | 2 | 0 | 2 |
Glutamate carboxypeptidase 2 | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 1 | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2A | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, kainate 2 | 0 | 1 | 1 | 2 |
Glutamate receptor ionotropic, kainate 3 | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2B | 0 | 1 | 0 | 1 |
Metabotropic glutamate receptor 1 | 0 | 1 | 1 | 3 |
Metabotropic glutamate receptor 2 | 0 | 1 | 1 | 3 |
Metabotropic glutamate receptor 7 | 0 | 1 | 1 | 3 |
Metabotropic glutamate receptor 3 | 0 | 1 | 1 | 3 |
Metabotropic glutamate receptor 4 | 0 | 1 | 1 | 3 |
Glutamate receptor ionotropic, NMDA 2C | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, kainate 5 | 0 | 1 | 0 | 1 |
Carbonic anhydrase-like protein, putative | 0 | 0 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2D | 0 | 2 | 1 | 3 |
Glutamate receptor ionotropic, kainate 5 | 0 | 2 | 0 | 2 |
Glutamate racemase | 0 | 0 | 0 | 1 |
Prolyl 4-hydroxylase | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 3A | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 3B | 0 | 2 | 1 | 3 |
Alpha-ketoglutarate-dependent dioxygenase FTO | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 3A | 0 | 2 | 1 | 3 |
Chymotrypsinogen A | 0 | 2 | 0 | 2 |
Solute carrier organic anion transporter family member 2A1 | 0 | 1 | 0 | 1 |
Beta-2 adrenergic receptor | 0 | 3 | 0 | 3 |
Beta-1 adrenergic receptor | 0 | 3 | 0 | 3 |
5-hydroxytryptamine receptor 1A | 0 | 2 | 1 | 3 |
D(2) dopamine receptor | 0 | 3 | 1 | 4 |
D(4) dopamine receptor | 0 | 3 | 0 | 3 |
D(1B) dopamine receptor | 0 | 1 | 0 | 1 |
Catechol O-methyltransferase | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 1D | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 2A | 0 | 4 | 1 | 5 |
5-hydroxytryptamine receptor 2C | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 1E | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 7 | 0 | 2 | 0 | 2 |
Histamine H1 receptor | 0 | 1 | 0 | 1 |
D(3) dopamine receptor | 0 | 5 | 0 | 5 |
5-hydroxytryptamine receptor 2B | 0 | 3 | 0 | 3 |
5-hydroxytryptamine receptor 5A | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 6 | 0 | 2 | 0 | 2 |
Sodium-dependent dopamine transporter | 0 | 2 | 0 | 2 |
D | 0 | 2 | 0 | 2 |
Sodium-dependent dopamine transporter | 0 | 1 | 0 | 1 |
Polyphenol oxidase 2 | 0 | 4 | 0 | 6 |
Dopamine beta-hydroxylase | 0 | 2 | 0 | 2 |
Lactoperoxidase | 0 | 1 | 0 | 1 |
Lanosterol 14-alpha demethylase | 0 | 1 | 0 | 1 |
Chain A, Inosine-5'-Monophosphate Dehydrogenase 2 | 0 | 1 | 0 | 1 |
UDP-glucuronosyltransferase 1A9 | 0 | 0 | 0 | 2 |
Inosine-5'-monophosphate dehydrogenase 2 | 0 | 2 | 0 | 2 |
Inosine-5'-monophosphate dehydrogenase 1 | 0 | 2 | 0 | 2 |
UDP-glucuronosyltransferase 1A1 | 0 | 0 | 0 | 1 |
Sodium-dependent serotonin transporter | 0 | 1 | 0 | 1 |
Peroxisome proliferator-activated receptor gamma | 0 | 0 | 1 | 1 |
Inosine-5'-monophosphate dehydrogenase | 0 | 1 | 0 | 2 |
UDP-glucuronosyltransferase 1A7 | 0 | 0 | 0 | 1 |
UDP-glucuronosyltransferase 1A10 | 0 | 0 | 0 | 1 |
UDP-glucuronosyltransferase 1A8 | 0 | 0 | 0 | 1 |
30S ribosomal protein S6 | 0 | 1 | 0 | 1 |
30S ribosomal protein S7 | 0 | 1 | 0 | 1 |
50S ribosomal protein L15 | 0 | 1 | 0 | 1 |
50S ribosomal protein L10 | 0 | 1 | 0 | 1 |
50S ribosomal protein L11 | 0 | 1 | 0 | 1 |
50S ribosomal protein L7/L12 | 0 | 1 | 0 | 1 |
50S ribosomal protein L19 | 0 | 1 | 0 | 1 |
50S ribosomal protein L1 | 0 | 1 | 0 | 1 |
50S ribosomal protein L20 | 0 | 1 | 0 | 1 |
50S ribosomal protein L27 | 0 | 1 | 0 | 1 |
50S ribosomal protein L28 | 0 | 1 | 0 | 1 |
50S ribosomal protein L29 | 0 | 1 | 0 | 1 |
50S ribosomal protein L31 | 0 | 1 | 0 | 1 |
50S ribosomal protein L31 type B | 0 | 1 | 0 | 1 |
50S ribosomal protein L32 | 0 | 1 | 0 | 1 |
50S ribosomal protein L33 | 0 | 1 | 0 | 1 |
50S ribosomal protein L34 | 0 | 1 | 0 | 1 |
50S ribosomal protein L35 | 0 | 1 | 0 | 1 |
50S ribosomal protein L36 | 0 | 1 | 0 | 1 |
30S ribosomal protein S10 | 0 | 1 | 0 | 1 |
30S ribosomal protein S11 | 0 | 1 | 0 | 1 |
30S ribosomal protein S12 | 0 | 1 | 0 | 1 |
30S ribosomal protein S13 | 0 | 1 | 0 | 1 |
30S ribosomal protein S16 | 0 | 1 | 0 | 1 |
30S ribosomal protein S18 | 0 | 1 | 0 | 1 |
30S ribosomal protein S19 | 0 | 1 | 0 | 1 |
30S ribosomal protein S20 | 0 | 1 | 0 | 1 |
30S ribosomal protein S2 | 0 | 1 | 0 | 1 |
30S ribosomal protein S3 | 0 | 1 | 0 | 1 |
30S ribosomal protein S4 | 0 | 1 | 0 | 1 |
30S ribosomal protein S5 | 0 | 1 | 0 | 1 |
30S ribosomal protein S8 | 0 | 1 | 0 | 1 |
30S ribosomal protein S9 | 0 | 1 | 0 | 1 |
50S ribosomal protein L13 | 0 | 1 | 0 | 1 |
50S ribosomal protein L14 | 0 | 1 | 0 | 1 |
50S ribosomal protein L16 | 0 | 1 | 0 | 1 |
50S ribosomal protein L23 | 0 | 1 | 0 | 1 |
30S ribosomal protein S15 | 0 | 1 | 0 | 1 |
50S ribosomal protein L17 | 0 | 1 | 0 | 1 |
50S ribosomal protein L21 | 0 | 1 | 0 | 1 |
50S ribosomal protein L30 | 0 | 1 | 0 | 1 |
50S ribosomal protein L6 | 0 | 1 | 0 | 1 |
30S ribosomal protein S14 | 0 | 1 | 0 | 1 |
30S ribosomal protein S17 | 0 | 1 | 0 | 1 |
30S ribosomal protein S1 | 0 | 1 | 0 | 1 |
50S ribosomal protein L18 | 0 | 1 | 0 | 1 |
50S ribosomal protein L2 | 0 | 1 | 0 | 1 |
50S ribosomal protein L3 | 0 | 1 | 0 | 1 |
50S ribosomal protein L24 | 0 | 1 | 0 | 1 |
50S ribosomal protein L4 | 0 | 1 | 0 | 1 |
50S ribosomal protein L22 | 0 | 1 | 0 | 1 |
50S ribosomal protein L5 | 0 | 1 | 0 | 1 |
30S ribosomal protein S21 | 0 | 1 | 0 | 1 |
50S ribosomal protein L25 | 0 | 1 | 0 | 1 |
50S ribosomal protein L36 2 | 0 | 1 | 0 | 1 |
Tyrosyl-DNA phosphodiesterase 1 | 0 | 1 | 0 | 1 |
Microphthalmia-associated transcription factor | 0 | 0 | 0 | 1 |
glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase | 0 | 1 | 0 | 1 |
caspase recruitment domain family, member 15 | 0 | 1 | 0 | 1 |
Caspase-7 | 2 | 0 | 0 | 2 |
glucose-6-phosphate 1-dehydrogenase isoform b | 0 | 1 | 0 | 1 |
parathyroid hormone/parathyroid hormone-related peptide receptor precursor | 3 | 0 | 0 | 3 |
caspase-3 | 2 | 0 | 0 | 2 |
histone deacetylase 9 isoform 3 | 1 | 0 | 0 | 1 |
receptor-interacting serine/threonine-protein kinase 2 isoform 1 | 0 | 1 | 0 | 1 |
ras-related protein Rab-9A | 3 | 0 | 0 | 3 |
serine/threonine-protein kinase PLK1 | 1 | 0 | 0 | 1 |
Solute carrier family 22 member 6 | 0 | 2 | 0 | 2 |
Nicotinate phosphoribosyltransferase | 0 | 2 | 0 | 2 |
GALC protein | 1 | 0 | 0 | 1 |
mu-type opioid receptor isoform MOR-1 | 0 | 0 | 1 | 1 |
5-hydroxytryptamine receptor 2A | 0 | 0 | 1 | 1 |
Neuronal acetylcholine receptor subunit alpha-4 | 1 | 0 | 0 | 1 |
Neuronal acetylcholine receptor subunit beta-2 | 1 | 0 | 0 | 1 |
Gamma-aminobutyric acid | 0 | 1 | 0 | 1 |
peripheral myelin protein 22 isoform 1 | 1 | 0 | 0 | 1 |
cytochrome P450 2C9 precursor | 1 | 0 | 0 | 1 |
atrial natriuretic peptide receptor 1 precursor | 1 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit pi | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit delta | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1F | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member B1 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit beta-1 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit delta | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit beta-3 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 0 | 1 | 0 | 1 |
Sodium channel protein type 1 subunit alpha | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit beta-2 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit beta-1 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit beta-3 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit epsilon | 0 | 1 | 0 | 1 |
Inositol monophosphatase 1 | 1 | 0 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 1 | 0 | 1 |
Sodium channel protein type 5 subunit alpha | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit pi | 0 | 1 | 0 | 1 |
Sodium channel protein type 2 subunit alpha | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit theta | 0 | 1 | 0 | 1 |
Sodium channel protein type 3 subunit alpha | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit theta | 0 | 1 | 0 | 1 |
Carbonic anhydrase 4 | 0 | 3 | 0 | 3 |
Carbonic anhydrase 5A, mitochondrial | 0 | 3 | 0 | 3 |
Taste receptor type 2 member 31 | 0 | 0 | 2 | 2 |
Taste receptor type 2 member 60 | 0 | 0 | 1 | 1 |
Carbonic anhydrase 9 | 0 | 3 | 0 | 3 |
Sodium/potassium/calcium exchanger 4 | 0 | 1 | 1 | 2 |
Taste receptor type 2 member 14 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 13 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 9 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 4 | 0 | 0 | 1 | 1 |
Sodium/potassium/calcium exchanger 2 | 0 | 1 | 1 | 2 |
Sigma non-opioid intracellular receptor 1 | 0 | 3 | 0 | 3 |
nonstructural protein 1 | 2 | 0 | 0 | 2 |
heat shock protein HSP 90-alpha isoform 2 | 0 | 0 | 0 | 1 |
heat shock protein 90, putative | 0 | 0 | 0 | 1 |
N | 0 | 1 | 0 | 1 |
dopamine D1 receptor | 1 | 0 | 0 | 1 |
NPYLR7B | 0 | 0 | 1 | 1 |
NPC intracellular cholesterol transporter 1 precursor | 2 | 0 | 0 | 2 |
cystic fibrosis transmembrane conductance regulator | 0 | 1 | 0 | 1 |
M-phase phosphoprotein 8 | 2 | 0 | 0 | 2 |
Riboflavin-binding protein | 0 | 1 | 1 | 2 |
Major prion protein | 0 | 1 | 0 | 1 |
Histidine-rich protein PFHRP-II | 0 | 2 | 0 | 2 |
Aldo-keto reductase family 1 member B1 | 0 | 4 | 0 | 4 |
Muscarinic acetylcholine receptor M2 | 0 | 3 | 0 | 3 |
Muscarinic acetylcholine receptor M4 | 0 | 3 | 0 | 3 |
ATP-dependent translocase ABCB1 | 0 | 2 | 1 | 4 |
Muscarinic acetylcholine receptor M1 | 0 | 2 | 0 | 2 |
Muscarinic acetylcholine receptor M3 | 0 | 2 | 0 | 2 |
Muscarinic acetylcholine receptor M4 | 0 | 2 | 0 | 2 |
Muscarinic acetylcholine receptor M5 | 0 | 2 | 0 | 2 |
Muscarinic acetylcholine receptor M5 | 0 | 3 | 0 | 3 |
Alpha-2A adrenergic receptor | 0 | 3 | 0 | 3 |
DNA-directed RNA polymerase subunit alpha | 0 | 1 | 0 | 1 |
DNA-directed RNA polymerase subunit omega | 0 | 1 | 0 | 1 |
DNA-directed RNA polymerase subunit beta' | 0 | 1 | 0 | 1 |
DNA-directed RNA polymerase subunit beta | 0 | 1 | 0 | 1 |
Muscarinic acetylcholine receptor M2 | 0 | 2 | 0 | 2 |
Muscarinic acetylcholine receptor M1 | 0 | 3 | 0 | 3 |
Phospholipase A2, membrane associated | 0 | 1 | 0 | 1 |
Phospholipase A2, membrane associated | 0 | 1 | 0 | 1 |
Acidic phospholipase A2 2 | 0 | 1 | 0 | 1 |
Alpha-2B adrenergic receptor | 0 | 2 | 0 | 2 |
Alpha-2C adrenergic receptor | 0 | 3 | 0 | 3 |
Muscarinic acetylcholine receptor M3 | 0 | 3 | 0 | 3 |
Sodium-dependent noradrenaline transporter | 0 | 2 | 0 | 2 |
Histamine H2 receptor | 0 | 2 | 0 | 2 |
Alpha-1D adrenergic receptor | 0 | 2 | 0 | 2 |
Trypanothione reductase | 0 | 2 | 0 | 2 |
Aldehyde oxidase 1 | 0 | 1 | 0 | 1 |
Aldehyde oxidase | 0 | 1 | 0 | 1 |
Cyclic GMP-AMP synthase | 0 | 1 | 0 | 1 |
2,3-bisphosphoglycerate-independent phosphoglycerate mutase | 1 | 0 | 0 | 1 |
Solute carrier family 22 member 1 | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 2 | 0 | 1 | 0 | 2 |
Solute carrier family 22 member 1 | 0 | 2 | 0 | 2 |
Solute carrier organic anion transporter family member 1A4 | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 2 | 0 | 1 | 0 | 1 |
Potassium channel subfamily K member 2 | 0 | 1 | 0 | 1 |
Albumin | 0 | 1 | 1 | 2 |
Cytochrome P450 2D1 | 0 | 1 | 0 | 1 |
Cytochrome P450 2D26 | 0 | 1 | 0 | 1 |
Cytochrome P450 2D6 | 0 | 3 | 1 | 4 |
Cytochrome P450 2D3 | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 1A1 | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 7 | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 1 | 0 | 2 | 0 | 3 |
Cytochrome P450 2D4 | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 2 | 0 | 2 | 0 | 2 |
Chain A, PLASMA RETINOL-BINDING PROTEIN PRECURSOR | 0 | 0 | 1 | 1 |
Retinol-binding protein 4 | 0 | 0 | 1 | 1 |
Beta-lactoglobulin | 0 | 0 | 1 | 1 |
Disintegrin and metalloproteinase domain-containing protein 17 | 3 | 0 | 0 | 3 |
Neuraminidase | 0 | 2 | 0 | 2 |
glycogen synthase kinase-3 beta isoform 1 | 0 | 0 | 1 | 1 |
L-lactate dehydrogenase A chain | 0 | 1 | 0 | 1 |
Albumin | 0 | 1 | 0 | 1 |
Neuraminidase | 0 | 1 | 0 | 1 |
Beta-lactamase | 0 | 1 | 0 | 1 |
Sialidase | 0 | 1 | 0 | 1 |
Cystic fibrosis transmembrane conductance regulator | 0 | 0 | 1 | 1 |
Dipeptidyl peptidase 4 | 0 | 1 | 0 | 1 |
Substance-P receptor | 0 | 1 | 0 | 1 |
Bifunctional epoxide hydrolase 2 | 0 | 1 | 0 | 1 |
Xanthine dehydrogenase/oxidase | 0 | 1 | 0 | 1 |
Prolyl endopeptidase | 0 | 1 | 0 | 1 |
Mitogen-activated protein kinase 10 | 0 | 1 | 0 | 1 |
Mitogen-activated protein kinase 14 | 0 | 1 | 0 | 1 |
Dihydroorotate dehydrogenase | 0 | 1 | 0 | 1 |
Substance-K receptor | 0 | 1 | 0 | 1 |
Neuromedin-U receptor 2 | 0 | 0 | 1 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Carbonic anhydrase 12 | 0 | 2 | 0 | 2 |
Carbonic anhydrase 3 | 0 | 2 | 0 | 2 |
D(3) dopamine receptor | 0 | 2 | 0 | 3 |
Carbonic anhydrase 6 | 0 | 2 | 0 | 2 |
Delta-type opioid receptor | 0 | 1 | 0 | 1 |
Delta-type opioid receptor | 0 | 1 | 0 | 1 |
Mu-type opioid receptor | 0 | 1 | 0 | 1 |
Carbonic anhydrase 7 | 0 | 2 | 0 | 2 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Mu-type opioid receptor | 0 | 1 | 0 | 1 |
Beta-carbonic anhydrase 1 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Carbonic anhydrase, alpha family | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Delta carbonic anhydrase | 0 | 1 | 0 | 1 |
RmtA | 0 | 1 | 0 | 1 |
Protein arginine N-methyltransferase 1 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 14 | 0 | 2 | 0 | 2 |
Carbonic anhydrase 5B, mitochondrial | 0 | 2 | 0 | 2 |
Estrogen receptor beta | 0 | 0 | 0 | 1 |
Inhibitor of nuclear factor kappa-B kinase subunit beta | 0 | 0 | 0 | 1 |
5'-AMP-activated protein kinase subunit beta-2 | 0 | 0 | 0 | 1 |
Polymerase acidic protein | 0 | 0 | 1 | 1 |
Stromelysin-1 | 0 | 0 | 1 | 1 |
Tyrosine-protein phosphatase YopH | 0 | 1 | 0 | 1 |
High mobility group protein B1 | 0 | 0 | 1 | 1 |
Aldo-keto reductase family 1 member B1 | 0 | 1 | 0 | 1 |
Prolyl 4-hydroxylase subunit alpha-1 | 0 | 1 | 0 | 1 |
Tyrosine-protein phosphatase non-receptor type 1 | 0 | 1 | 0 | 3 |
Estrogen receptor | 0 | 0 | 0 | 1 |
Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
Cystathionine gamma-lyase | 0 | 1 | 0 | 1 |
5'-AMP-activated protein kinase subunit gamma-1 | 0 | 0 | 0 | 1 |
5'-AMP-activated protein kinase catalytic subunit alpha-2 | 0 | 0 | 0 | 1 |
Xanthine dehydrogenase/oxidase | 0 | 1 | 0 | 1 |
5'-AMP-activated protein kinase catalytic subunit alpha-1 | 0 | 0 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 6 | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 7 | 0 | 0 | 0 | 1 |
Solute carrier family 22 member 20 | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 8 | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 6 | 0 | 1 | 0 | 1 |
Ubiquitin-like domain-containing CTD phosphatase 1 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 15 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 13 | 0 | 1 | 0 | 1 |
5'-AMP-activated protein kinase subunit gamma-3 | 0 | 0 | 0 | 1 |
5'-AMP-activated protein kinase subunit gamma-2 | 0 | 0 | 0 | 1 |
5'-AMP-activated protein kinase subunit beta-1 | 0 | 0 | 0 | 1 |
alternatively spliced Trp4 | 0 | 0 | 1 | 1 |
5-hydroxytryptamine receptor 1E | 0 | 1 | 0 | 1 |
sphingosine 1-phosphate receptor 3 | 0 | 1 | 0 | 1 |
Beta-casein | 0 | 1 | 0 | 1 |
HLA class I histocompatibility antigen, A alpha chain | 0 | 0 | 1 | 1 |
Glycogen phosphorylase, brain form | 0 | 1 | 0 | 1 |
Glycogen phosphorylase, muscle form | 0 | 1 | 0 | 1 |
Alpha-1A adrenergic receptor | 0 | 2 | 0 | 2 |
D | 0 | 1 | 0 | 1 |
Alpha-2B adrenergic receptor | 0 | 1 | 0 | 1 |
Endothelin receptor type B | 0 | 1 | 0 | 1 |
D(1A) dopamine receptor | 0 | 1 | 0 | 1 |
Alpha-2C adrenergic receptor | 0 | 1 | 0 | 1 |
Alpha-2A adrenergic receptor | 0 | 1 | 0 | 1 |
Endothelin receptor type B | 0 | 1 | 0 | 1 |
D(1B) dopamine receptor | 0 | 1 | 0 | 1 |
D(3) dopamine receptor | 0 | 1 | 0 | 1 |
D(4) dopamine receptor | 0 | 1 | 0 | 1 |
Histamine H1 receptor | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 7 | 0 | 1 | 0 | 1 |
Alpha-1B adrenergic receptor | 0 | 1 | 0 | 1 |
D(4) dopamine receptor | 0 | 1 | 0 | 1 |
D(2) dopamine receptor | 0 | 1 | 0 | 1 |
D(2) dopamine receptor | 0 | 2 | 0 | 3 |
Vesicular acetylcholine transporter | 0 | 1 | 0 | 1 |
D(1B) dopamine receptor | 0 | 1 | 0 | 1 |
Replicase polyprotein 1ab | 0 | 1 | 0 | 1 |
Cereblon isoform 4 | 0 | 2 | 0 | 2 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4A | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 1 | 0 | 1 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4C | 0 | 1 | 0 | 1 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 0 | 1 | 0 | 1 |
DNA-binding protein Ikaros | 0 | 0 | 0 | 1 |
DNA damage-binding protein 1 | 0 | 1 | 1 | 2 |
Protein cereblon | 0 | 2 | 1 | 4 |
Thymidine kinase | 0 | 1 | 0 | 2 |
Thymidine phosphorylase | 0 | 0 | 0 | 1 |
Glucose-6-phosphate 1-dehydrogenase | 0 | 1 | 0 | 1 |
Thymidine kinase, cytosolic | 0 | 0 | 0 | 2 |
Thymidine kinase | 0 | 1 | 0 | 2 |
Sterol O-acyltransferase 1 | 0 | 1 | 0 | 1 |
Thymidine kinase | 0 | 0 | 0 | 1 |
Beta-1 adrenergic receptor | 0 | 0 | 1 | 1 |
Beta-3 adrenergic receptor | 0 | 2 | 0 | 2 |
Beta-1 adrenergic receptor | 0 | 1 | 0 | 1 |
Chain A, Nuclear Receptor ROR-beta | 0 | 1 | 0 | 1 |
Ornithine decarboxylase | 0 | 0 | 0 | 1 |
Cytochrome P450 1A2 | 0 | 0 | 1 | 1 |
Ornithine decarboxylase | 0 | 0 | 0 | 1 |
Adenosine receptor A3 | 0 | 2 | 0 | 2 |
Retinoic acid receptor alpha | 0 | 2 | 2 | 7 |
Retinoic acid receptor beta | 0 | 2 | 2 | 7 |
Retinoic acid receptor alpha | 0 | 1 | 2 | 3 |
Retinoic acid receptor gamma | 0 | 2 | 2 | 7 |
Retinoic acid receptor gamma | 0 | 1 | 2 | 3 |
Retinoic acid receptor RXR-alpha | 0 | 2 | 2 | 4 |
Retinoic acid receptor beta | 0 | 1 | 2 | 3 |
Cellular retinoic acid-binding protein 2 | 0 | 0 | 1 | 1 |
Mitogen-activated protein kinase 1 | 0 | 1 | 0 | 1 |
Retinoic acid receptor RXR-alpha | 0 | 1 | 2 | 3 |
Retinoic acid receptor RXR-beta | 0 | 2 | 2 | 4 |
Retinoic acid receptor RXR-beta | 0 | 1 | 2 | 3 |
Retinoic acid receptor RXR-gamma | 0 | 1 | 2 | 3 |
Indoleamine 2,3-dioxygenase 1 | 0 | 1 | 0 | 1 |
Cytochrome P450 2C19 | 0 | 0 | 1 | 1 |
Nuclear receptor ROR-alpha | 0 | 1 | 0 | 1 |
Cellular retinoic acid-binding protein 1 | 0 | 1 | 0 | 2 |
Retinoic acid receptor RXR-gamma | 0 | 2 | 2 | 4 |
Cellular retinoic acid-binding protein 1 | 0 | 0 | 1 | 1 |
Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 0 | 2 | 1 | 3 |
Indoleamine 2,3-dioxygenase 2 | 0 | 1 | 0 | 1 |
Nuclear receptor ROR-beta | 0 | 1 | 0 | 1 |
Cocaine esterase | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member A1 | 0 | 1 | 0 | 1 |
UDP-glucuronosyltransferase 1-6 | 0 | 0 | 0 | 1 |
Liver carboxylesterase 1 | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member A1 | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member A1 | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member B7 | 0 | 1 | 0 | 1 |
NAD-dependent protein deacylase sirtuin-5, mitochondrial | 0 | 1 | 0 | 1 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |